Juan Garona

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Pathway-driven therapeutic stratification in pancreatic ductal adenocarcinoma.

Pathway-driven therapeutic stratification in pancreatic ductal adenocarcinoma.

Journal: Translational oncology

Published: May 11, 2026

Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma.

Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma.

Journal: Frontiers in medicine

Published: April 24, 2026

In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human Osteosarcoma.

In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human Osteosarcoma.

Journal: Pharmaceutics

Published: December 16, 2025

Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities.

Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities.

Journal: iScience

Published: September 24, 2025

Wound Healing Potential of a Formulation Containing Yerba Mate (Ilex paraguariensis) Extract: A Preclinical Study in a Rat Model of Undernutrition.

Wound Healing Potential of a Formulation Containing Yerba Mate (Ilex paraguariensis) Extract: A Preclinical Study in a Rat Model of Undernutrition.

Journal: Journal of food science

Published: April 04, 2025

The impact of topical tranexamic acid on drain duration and seroma volume in axillary lymph node dissection for breast cancer: A randomized controlled trial.

The impact of topical tranexamic acid on drain duration and seroma volume in axillary lymph node dissection for breast cancer: A randomized controlled trial.

Journal: World journal of surgery

Published: December 03, 2024

Development of an efficient NUPR1 inhibitor with anticancer activity.

Development of an efficient NUPR1 inhibitor with anticancer activity.

Journal: Scientific reports

Published: May 05, 2024

Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models.

Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models.

Journal: World journal of oncology

Published: August 22, 2023

The mRNA vaccine for the treatment of pancreatic cancer is here to stay

The mRNA vaccine for the treatment of pancreatic cancer is here to stay

Journal: Medicina

Published: August 15, 2023

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma.

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma.

Journal: Animals : an open access journal from MDPI

Published: June 28, 2023

Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models.

Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models.

Journal: Chemico-biological interactions

Published: May 16, 2023

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy.

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy.

Journal: Scientific reports

Published: December 14, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026